Home » Topics » Regulatory » Patents

Patents
RSS

Novel antitumor/immunomodulatory agents isolated by Japanese investigators

Jan. 9, 1997

Potential HIV-1 therapy disclosed by Houghten

Jan. 9, 1997

KGF receptor antagonists developed by U.S. researchers

Jan. 9, 1997

High-affinity inhibitor of biogenic amine transporters described

Jan. 9, 1997

Pharmacia & Upjohn describes selective 5-HT2 antagonists

Jan. 9, 1997

Galderma develops novel compounds active on cell differentiation and proliferation

Jan. 9, 1997

Hoechst Japan describes immunosuppressive peptides

Jan. 8, 1997

Zeneca describes nonpeptide antagonists of NK2 receptors

Jan. 8, 1997

Anti-HCV agents revealed by Japanese and Chinese investigators

Jan. 8, 1997

Prokinetic agents from Tokyo Tanabe

Jan. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.